Should we B-leavin' now?
Gunn
Michael D
MD
Kelsoe
Garnett
G
D000818:Animals; D001402:B-Lymphocytes / Q000166:cytology* / Q000187:drug effects / Q000276:immunology* / Q000378:metabolism; D054382:Chemokine CXCL13; D019743:Chemokines, CXC / Q000378:metabolism; D002633:Chemotaxis / Q000187:drug effects; D000068876:Fingolimod Hydrochloride; D051379:Mice; D011409:Propylene Glycols / Q000494:pharmacology; D043562:Receptors, G-Protein-Coupled / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D049312:Receptors, Lysophospholipid; D013110:Sphingosine / Q000031:analogs & derivatives
D054382:Chemokine CXCL13; D019743:Chemokines, CXC; C486386:Cxcl13 protein, mouse; D011409:Propylene Glycols; D043562:Receptors, G-Protein-Coupled; D049312:Receptors, Lysophospholipid; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine